Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9NM6
|
||||
| Drug Name |
((R)-5-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-methyl-(2-quinoxalin-6-yl-ethyl)-amine
|
||||
| Synonyms |
CHEMBL9924
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H27N3O
|
||||
| Canonical SMILES |
COc1cccc2[C@H](CN(C)CCc3ccc4nccnc4c3)CCCc12
|
||||
| InChI |
InChI=1S/C23H27N3O/c1-26(14-11-17-9-10-21-22(15-17)25-13-12-24-21)16-18-5-3-7-20-19(18)6-4-8-23(20)27-2/h4,6,8-10,12-13,15,18H,3,5,7,11,14,16H2,1-2H3/t18-/m0/s1
|
||||
| InChIKey |
OEMXCGIPZRQFGM-SFHVURJKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.